MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors
Cancer immunotherapy critically depends on fitness of cytotoxic and helper T cell responses. Dysfunctional cytotoxic T cell states in the tumor microenvironment (TME) are a major cause of resistance to immunotherapy. Intratumoral myeloid cells, particularly blood-borne myeloids (bbm), are key driver...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
13 January 2023
|
| In: |
Cancer cell
Year: 2023, Volume: 41, Issue: 2, Pages: 235-251 |
| ISSN: | 1878-3686 |
| DOI: | 10.1016/j.ccell.2022.12.007 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ccell.2022.12.007 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1535610822005931 |
| Author Notes: | Michael Kilian, Ron Sheinin, Chin Leng Tan, Mirco Friedrich, Christopher Krämer, Ayelet Kaminitz, Khwab Sanghvi, Katharina Lindner, Yu-Chan Chih, Frederik Cichon, Benjamin Richter, Stefanie Jung, Kristine Jähne, Miriam Ratliff, Robert M. Prins, Nima Etminan, Andreas von Deimling, Wolfgang Wick, Asaf Madi, Lukas Bunse, and Michael Platten |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1832484084 | ||
| 003 | DE-627 | ||
| 005 | 20250109092130.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230126s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ccell.2022.12.007 |2 doi | |
| 035 | |a (DE-627)1832484084 | ||
| 035 | |a (DE-599)KXP1832484084 | ||
| 035 | |a (OCoLC)1389533349 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kilian, Michael |d 1990- |e VerfasserIn |0 (DE-588)1220319422 |0 (DE-627)1736693255 |4 aut | |
| 245 | 1 | 0 | |a MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors |c Michael Kilian, Ron Sheinin, Chin Leng Tan, Mirco Friedrich, Christopher Krämer, Ayelet Kaminitz, Khwab Sanghvi, Katharina Lindner, Yu-Chan Chih, Frederik Cichon, Benjamin Richter, Stefanie Jung, Kristine Jähne, Miriam Ratliff, Robert M. Prins, Nima Etminan, Andreas von Deimling, Wolfgang Wick, Asaf Madi, Lukas Bunse, and Michael Platten |
| 264 | 1 | |c 13 January 2023 | |
| 300 | |a 27 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar 12 January 2023, Version des Artikels 13 February 2023 | ||
| 500 | |a Gesehen am 26.01.2023 | ||
| 520 | |a Cancer immunotherapy critically depends on fitness of cytotoxic and helper T cell responses. Dysfunctional cytotoxic T cell states in the tumor microenvironment (TME) are a major cause of resistance to immunotherapy. Intratumoral myeloid cells, particularly blood-borne myeloids (bbm), are key drivers of T cell dysfunction in the TME. We show here that major histocompatibility complex class II (MHCII)-restricted antigen presentation on bbm is essential to control the growth of brain tumors. Loss of MHCII on bbm drives dysfunctional intratumoral tumor-reactive CD8+ T cell states through increased chromatin accessibility and expression of Tox, a critical regulator of T cell exhaustion. Mechanistically, MHCII-dependent activation of CD4+ T cells restricts myeloid-derived osteopontin that triggers a chronic activation of NFAT2 in tumor-reactive CD8+ T cells. In summary, we provide evidence that MHCII-restricted antigen presentation on bbm is a key mechanism to directly maintain functional cytotoxic T cell states in brain tumors. | ||
| 650 | 4 | |a CD8 T cell dysfunction | |
| 650 | 4 | |a glioblastoma | |
| 650 | 4 | |a glioma | |
| 650 | 4 | |a macrophages | |
| 650 | 4 | |a MHC class II | |
| 650 | 4 | |a microenvironment | |
| 650 | 4 | |a myeloid cells | |
| 650 | 4 | |a NFAT | |
| 650 | 4 | |a osteopontin | |
| 650 | 4 | |a TOX | |
| 700 | 1 | |a Sheinin, Ron |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tan, Chin Leng |e VerfasserIn |0 (DE-588)125452441X |0 (DE-627)1797000837 |4 aut | |
| 700 | 1 | |a Friedrich, Mirco |e VerfasserIn |0 (DE-588)1126663794 |0 (DE-627)881255246 |0 (DE-576)484646923 |4 aut | |
| 700 | 1 | |a Krämer, Christopher |d 1997- |e VerfasserIn |0 (DE-588)1279191635 |0 (DE-627)1832479978 |4 aut | |
| 700 | 1 | |a Kaminitz, Ayelet |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sanghvi, Khwab |d 1990- |e VerfasserIn |0 (DE-588)1201828864 |0 (DE-627)1685962580 |4 aut | |
| 700 | 1 | |a Lindner, Katharina |d 1994- |e VerfasserIn |0 (DE-588)1308397348 |0 (DE-627)1869026217 |4 aut | |
| 700 | 1 | |a Chih, Yu-Chan |d 1997- |e VerfasserIn |0 (DE-588)1317602609 |0 (DE-627)1879494531 |4 aut | |
| 700 | 1 | |a Cichon, Frederik |d 1983- |e VerfasserIn |0 (DE-588)1220319589 |0 (DE-627)1736693700 |4 aut | |
| 700 | 1 | |a Richter, Benjamin |e VerfasserIn |0 (DE-588)1279194502 |0 (DE-627)1832482286 |4 aut | |
| 700 | 1 | |a Jung, Stefanie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jähne, Kristine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ratliff, Miriam |d 1979- |e VerfasserIn |0 (DE-588)1012081028 |0 (DE-627)660894602 |0 (DE-576)344899357 |4 aut | |
| 700 | 1 | |a Prins, Robert M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Etminan, Nima |d 1978- |e VerfasserIn |0 (DE-588)134245202 |0 (DE-627)56561374X |0 (DE-576)300399871 |4 aut | |
| 700 | 1 | |a Deimling, Andreas von |d 1959- |e VerfasserIn |0 (DE-588)103034115X |0 (DE-627)735093946 |0 (DE-576)378138065 |4 aut | |
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 700 | 1 | |a Madi, Asaf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bunse, Lukas |d 1988- |e VerfasserIn |0 (DE-588)1051941229 |0 (DE-627)787187399 |0 (DE-576)407600426 |4 aut | |
| 700 | 1 | |a Platten, Michael |d 1971- |e VerfasserIn |0 (DE-588)121627780 |0 (DE-627)081431848 |0 (DE-576)261969811 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer cell |d Cambridge, Mass. : Cell Press, 2002 |g 41(2023), 2, Seite 235-251 |h Online-Ressource |w (DE-627)343970082 |w (DE-600)2074034-7 |w (DE-576)097935972 |x 1878-3686 |7 nnas |a MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors |
| 773 | 1 | 8 | |g volume:41 |g year:2023 |g number:2 |g pages:235-251 |g extent:27 |a MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ccell.2022.12.007 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1535610822005931 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230126 | ||
| 994 | |a 2023 | ||
| 998 | |g 121627780 |a Platten, Michael |m 121627780:Platten, Michael |d 60000 |d 62700 |e 60000PP121627780 |e 62700PP121627780 |k 0/60000/ |k 1/60000/62700/ |p 21 |y j | ||
| 998 | |g 1051941229 |a Bunse, Lukas |m 1051941229:Bunse, Lukas |d 60000 |d 62700 |e 60000PB1051941229 |e 62700PB1051941229 |k 0/60000/ |k 1/60000/62700/ |p 20 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 60000 |d 62700 |e 60000PW120297736 |e 62700PW120297736 |k 0/60000/ |k 1/60000/62700/ |p 18 | ||
| 998 | |g 103034115X |a Deimling, Andreas von |m 103034115X:Deimling, Andreas von |d 60000 |d 63400 |e 60000PD103034115X |e 63400PD103034115X |k 0/60000/ |k 1/60000/63400/ |p 17 | ||
| 998 | |g 134245202 |a Etminan, Nima |m 134245202:Etminan, Nima |d 60000 |d 62600 |e 60000PE134245202 |e 62600PE134245202 |k 0/60000/ |k 1/60000/62600/ |p 16 | ||
| 998 | |g 1012081028 |a Ratliff, Miriam |m 1012081028:Ratliff, Miriam |p 14 | ||
| 998 | |g 1279194502 |a Richter, Benjamin |m 1279194502:Richter, Benjamin |d 60000 |e 60000PR1279194502 |k 0/60000/ |p 11 | ||
| 998 | |g 1317602609 |a Chih, Yu-Chan |m 1317602609:Chih, Yu-Chan |d 140000 |e 140000PC1317602609 |k 0/140000/ |p 9 | ||
| 998 | |g 1308397348 |a Lindner, Katharina |m 1308397348:Lindner, Katharina |d 140000 |e 140000PL1308397348 |k 0/140000/ |p 8 | ||
| 998 | |g 1201828864 |a Sanghvi, Khwab |m 1201828864:Sanghvi, Khwab |d 60000 |d 62700 |e 60000PS1201828864 |e 62700PS1201828864 |k 0/60000/ |k 1/60000/62700/ |p 7 | ||
| 998 | |g 1279191635 |a Krämer, Christopher |m 1279191635:Krämer, Christopher |d 60000 |e 60000PK1279191635 |k 0/60000/ |p 5 | ||
| 998 | |g 1126663794 |a Friedrich, Mirco |m 1126663794:Friedrich, Mirco |d 910000 |d 910100 |e 910000PF1126663794 |e 910100PF1126663794 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 125452441X |a Tan, Chin Leng |m 125452441X:Tan, Chin Leng |d 140000 |e 140000PT125452441X |k 0/140000/ |p 3 | ||
| 998 | |g 1220319422 |a Kilian, Michael |m 1220319422:Kilian, Michael |d 60000 |e 60000PK1220319422 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1832484084 |e 4252203910 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Online verfügbar 12 January 2023, Version des Artikels 13 February 2023","Gesehen am 26.01.2023"],"language":["eng"],"person":[{"given":"Michael","family":"Kilian","role":"aut","display":"Kilian, Michael"},{"role":"aut","family":"Sheinin","display":"Sheinin, Ron","given":"Ron"},{"display":"Tan, Chin Leng","family":"Tan","role":"aut","given":"Chin Leng"},{"given":"Mirco","display":"Friedrich, Mirco","role":"aut","family":"Friedrich"},{"given":"Christopher","family":"Krämer","role":"aut","display":"Krämer, Christopher"},{"given":"Ayelet","display":"Kaminitz, Ayelet","family":"Kaminitz","role":"aut"},{"given":"Khwab","display":"Sanghvi, Khwab","family":"Sanghvi","role":"aut"},{"given":"Katharina","role":"aut","family":"Lindner","display":"Lindner, Katharina"},{"role":"aut","family":"Chih","display":"Chih, Yu-Chan","given":"Yu-Chan"},{"given":"Frederik","family":"Cichon","role":"aut","display":"Cichon, Frederik"},{"given":"Benjamin","display":"Richter, Benjamin","role":"aut","family":"Richter"},{"given":"Stefanie","family":"Jung","role":"aut","display":"Jung, Stefanie"},{"display":"Jähne, Kristine","family":"Jähne","role":"aut","given":"Kristine"},{"given":"Miriam","display":"Ratliff, Miriam","family":"Ratliff","role":"aut"},{"given":"Robert M.","display":"Prins, Robert M.","family":"Prins","role":"aut"},{"given":"Nima","role":"aut","family":"Etminan","display":"Etminan, Nima"},{"given":"Andreas von","display":"Deimling, Andreas von","family":"Deimling","role":"aut"},{"display":"Wick, Wolfgang","family":"Wick","role":"aut","given":"Wolfgang"},{"role":"aut","family":"Madi","display":"Madi, Asaf","given":"Asaf"},{"role":"aut","family":"Bunse","display":"Bunse, Lukas","given":"Lukas"},{"family":"Platten","role":"aut","display":"Platten, Michael","given":"Michael"}],"id":{"eki":["1832484084"],"doi":["10.1016/j.ccell.2022.12.007"]},"recId":"1832484084","type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Michael Kilian, Ron Sheinin, Chin Leng Tan, Mirco Friedrich, Christopher Krämer, Ayelet Kaminitz, Khwab Sanghvi, Katharina Lindner, Yu-Chan Chih, Frederik Cichon, Benjamin Richter, Stefanie Jung, Kristine Jähne, Miriam Ratliff, Robert M. Prins, Nima Etminan, Andreas von Deimling, Wolfgang Wick, Asaf Madi, Lukas Bunse, and Michael Platten"]},"origin":[{"dateIssuedDisp":"13 January 2023","dateIssuedKey":"2023"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"eki":["343970082"],"zdb":["2074034-7"],"issn":["1878-3686"]},"recId":"343970082","origin":[{"dateIssuedKey":"2002","publisherPlace":"Cambridge, Mass. ; New York, NY","dateIssuedDisp":"2002-","publisher":"Cell Press ; Elsevier"}],"disp":"MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumorsCancer cell","language":["eng"],"note":["Gesehen am 28.02.11"],"pubHistory":["1.2002 -"],"part":{"volume":"41","text":"41(2023), 2, Seite 235-251","extent":"27","issue":"2","pages":"235-251","year":"2023"},"title":[{"title_sort":"Cancer cell","title":"Cancer cell"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"27 S."}],"title":[{"title":"MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors","title_sort":"MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors"}]} | ||
| SRT | |a KILIANMICHMHCCLASSII1320 | ||